AudioAbstracts

A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results

July 27, 20164 min
Host: Thomas C. Wright, Jr., MD A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results Schiffman M1, Vaughan LM2, Raine-Bennett TR3, Castle PE4, Katki HA5, Gage JC5, Fetterman B6, Befano B7, Wentzensen N5. Gynecol Oncol. 2015 Sep;138(3):573-8. doi: 10.1016/j.ygyno.2015.06.040. Epub 2015 Jul 4. Reviewed by: Thomas C. Wright Jr., MD Interpretation: HPV testing is now a well-established as an integral component of cervical cancer screening. In the US, almost all women 25 years and older with an ASC-US cytology result are triaged using HPV testing. Similarly, since the joint American Cancer Society/ASCCP 2012 cervical cancer screening guidelines made co-testing with both cervical cytology and HPV testing the preferred approach to screening women 30 years and older, there has been widespread adoption of co-testing for screening in this age group. The availability of genotyping assays for HPV 16 and 18 has made co-testing even more attractive since

Chat About A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results